Living liver donors improve survival rates in liver cancer patients
Posted Sep 27 2011 8:14am
A study conducted by the American Association for the Study of Liver Diseases due to be published in Hepatology in October found that patients who have received a living donor liverA large abdominal organ that has many important roles including the production of bile and clotting factors, detoxification, and the metabolism of proteins, carbohydrates and fats. transplant (LDLT) have greater survival rates than those waiting for a deceased donor liver transplant (DDLT).
Transplantation is recommended for patients in end-stage liver disease when their lives are deemed to be at risk. In the first half of 2011 over 3000 liver transplants were performed in the US, with roughly 96% being DDLTs and 4% LDLTs.
The patients who received LDLTs as part of the study had a 56% lower risk of death than those on the waiting lists for DDLT. This research is posing questions regarding the optimum time for transplantation although future follow-up studies are needed to validate quality of life in those patients who received LDLTs.